Involved field (IF) radiotherapy is as effective as extended field (EF) radiotherapy after 2 cycles of COPP/ABVD in patients (pts) with intermediate-stage Hodgkin's disease (HD): A randomized multicenter study.

被引：0
|
作者：
Engert, A [1 ]
Schiller, P [1 ]
Pfistner, B [1 ]
Herrmann, R [1 ]
Koch, P [1 ]
Bossevin, F [1 ]
Schaber, R [1 ]
Loeffler, M [1 ]
Duehmke, F [1 ]
Mueller-Hermelink, HK [1 ]
Paulus, U [1 ]
Rueffer, JU [1 ]
Sieber, M [1 ]
Wolf, J [1 ]
Diehl, V [1 ]
机构：
[1] Univ Cologne, German Hodgkins Study Grp, Med Ctr, Cologne, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3199
引用
收藏
页码：768A / 768A
页数：1
相关论文
共 50 条
  • [41] Intensified Chemotherapy and Dose-Reduced Involved Field Radiotherapy in Patients with Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) Randomized HD11 Trial
    Eich, H. T.
    Mueller, R. P.
    Diehl, V.
    Goergen, H.
    Mueller-Hermelink, H.
    Schmidt, B.
    Grosu, A.
    Karstens, J.
    Willich, N.
    Engert, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S1 - S1
  • [42] Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial
    Eich, Hans Theodor
    Diehl, Volker
    Goergen, Helen
    Pabst, Thomas
    Markova, Jana
    Debus, Juergen
    Ho, Anthony
    Doerken, Bernd
    Rank, Andreas
    Grosu, Anca-Ligia
    Wiegel, Thomas
    Karstens, Johann Hinrich
    Greil, Richard
    Willich, Normann
    Schmidberger, Heinz
    Doehner, Hartmut
    Borchmann, Peter
    Mueller-Hermelink, Hans-Konrad
    Mueller, Rolf-Peter
    Engert, Andreas
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) : 4199 - 4206
  • [43] Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease
    Dawson, LA
    Saito, NG
    Ratanatharathorn, V
    Uberti, JP
    Adams, PT
    Ayash, LJ
    Reynolds, CM
    Silver, SM
    Schipper, MJ
    Lichter, AS
    Eisbruch, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (01): : 208 - 218
  • [44] OUTCOMES FOLLOWING INVOLVED FIELD RADIOTHERAPY (IFRT) WITH OR WITHOUT RITUXAN IN PATIENTS (PTS) WITH EARLY STAGE LOW-GRADE NON-HODGKIN'S LYMPHOMA (NHL) STAGED WITH CT VERSUS PET
    Lukens, J.
    Nasta, S.
    Glatstein, E.
    Plastaras, J.
    ANNALS OF ONCOLOGY, 2011, 22 : 217 - 218
  • [45] A contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stage Hodgkin's lymphoma - Fourth interim analysis of the multicenter randomized trial HD12 of the German Hodgkin study group (GHSG)
    Eich, H. T.
    Mueller, R. P.
    Brillant, C.
    Engert, A.
    Franklin, J.
    Hansemann, K.
    Skripnitchenko, R.
    Staar, S.
    Pfistner, B.
    Diehl, V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S96 - S97
  • [46] Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review Comparison of the results between two study generations of the German Hodgkin Study Group
    Kriz, J.
    Bangard, C.
    Haverkamp, U.
    Bongartz, R.
    Baues, C.
    Engert, A.
    Mueller, R-P
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (08) : 660 - 665
  • [47] Risk-oriented therapy in adults previously untreated Hodgkin's lymphoma (HL) with ABVD followed by involved field radiotherapy (IFRT). Final results of the Argentinian group for treatment of acute leukemia (GATLA) phase III study.
    Belgaumi, Asim F.
    Al-Kofide, Amani A.
    Joseph, Nicey
    Khafaga, Yasser
    Malik, Rubina J.
    Mourad, Walid
    Mohamed, Gamal-Eldin H.
    Sabbah, Rajih S.
    BLOOD, 2006, 108 (11) : 700A - 700A
  • [48] EFFICACY OF LOW-DOSE INVOLVED-FIELD RADIOTHERAPY FOLLOWING 3-4 CYCLES OF CHEMOTHERAPY FOR PATIENTS WITH STAGE I-II AGGRESSIVE NON-HODGKIN'S LYMPHOMA
    Gauthier, I.
    Despres, P.
    Roy, I.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S14 - S14
  • [49] Results of the 2nd Planned Interim Analysis of the RAPID Trial (involved field radiotherapy versus no further treatment) in Patients with Clinical Stages 1A and 2A Hodgkin Lymphoma and a 'negative' FDG-PET Scan after 3 Cycles ABVD
    Radford, John
    O'Doherty, Michael
    Barrington, Sally
    Qian, Wendi
    Patrick, Philippa
    Coltart, Stewart
    Culligan, Dominic
    Wimperis, Jennie
    Bessell, Eric
    Linch, David
    Johnson, Peter
    Cunningham, David
    Lister, T. Andrew
    Hoskin, Peter
    Pettengell, Ruth
    Hancock, Bary
    Illidge, Timothy
    BLOOD, 2008, 112 (11) : 143 - 144
  • [50] 100% of complete response (CR) and survival (FFP, OS) in newly diagnosed patients with advanced- and intermediate-stage Hodgkin's lymphoma (HL) treated with six cycles of dose-dense, dose-intense (DD-DI) ABVD without radiotherapy (RT).
    Russo, Filippo
    Corazzelli, Gaetano
    Frigeri, Ferdinando
    LaStoria, Secondo
    Pinto, Antonio
    BLOOD, 2006, 108 (11) : 701A - 701A
12345